Literature DB >> 8299268

Does dapsone have a role in the treatment of temporal arteritis with regard to efficacy and toxicity?

F Liozon, E Vidal, J Barrier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8299268

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  7 in total

Review 1.  Polymyalgia rheumatica/temporal arteritis: recent advances.

Authors:  Maria-Louise Barilla-LaBarca; Deborah J Lenschow; Richard D Brasington
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

Review 2.  The treatment of giant cell arteritis.

Authors:  J Alexander Fraser; Cornelia M Weyand; Nancy J Newman; Valérie Biousse
Journal:  Rev Neurol Dis       Date:  2008

3.  [Off-label biological therapies in patients with large vessel vasculitis and/or polymyalgia rheumatica : Safety and efficacy analysis of a nationwide German registry (GRAID2)].

Authors:  J C Henes; H Schulze-Koops; M Witt; H P Tony; F Mueller; M Grunke; M Czihal; T Dörner; F Proft
Journal:  Z Rheumatol       Date:  2018-02       Impact factor: 1.372

Review 4.  The Treatment of Giant Cell Arteritis.

Authors:  Imran Jivraj; Madhura Tamhankar
Journal:  Curr Treat Options Neurol       Date:  2017-01       Impact factor: 3.598

Review 5.  Recent advances in temporal arteritis.

Authors:  Carol Redillas; Seymour Solomon
Journal:  Curr Pain Headache Rep       Date:  2003-08

Review 6.  Treatment of Giant Cell Arteritis (GCA).

Authors:  Alexis Régent; Luc Mouthon
Journal:  J Clin Med       Date:  2022-03-24       Impact factor: 4.241

7.  Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis.

Authors:  Sara Monti; Ana F Águeda; Raashid Ahmed Luqmani; Frank Buttgereit; Maria Cid; Christian Dejaco; Alfred Mahr; Cristina Ponte; Carlo Salvarani; Wolfgang Schmidt; Bernhard Hellmich
Journal:  RMD Open       Date:  2019-09-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.